A diagnostic test for the assessment and diagnosis of dementia in elderly patients using molecular biomarkers.
Manufactured by
Origin Biotechnology Co., Ltd.
Taipei, Taiwan
Origin is an innovative biotechnology company based on autonomous research and development in the field of molecular diagnostics. Our business strategy aims to develop a rapid, accurate IVD kit to fulfill unresolved clinical demands. Our mission focuses on prevention, screening, and diagnosis of gynecological, pediatric, and genetic diseases.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
BioChain (Beijing) Science & Technology. Inc.
China · 3 relevant products
ADmit Therapeutics SL
Spain · 2 relevant products
Fujirebio Diagnostics,Inc.
China · 5 relevant products
55 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →15 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 100 closest product alternatives
BioChain (Beijing) Science & Technology. Inc. · China
Diagnostic test for early detection of cognitive impairment and neurodegenerative disease risk. This biomarker-based test supports early intervention strategies for age-related cognitive disorders. The product aligns with research collaborations in epigenetic disease markers.
ADmit Therapeutics SL · Spain
A CE-marked in vitro diagnostic test that predicts progression from Mild Cognitive Impairment to Alzheimer's Disease Dementia using mitochondrial DNA epigenetic biomarkers. The test combines Next Generation Sequencing and Machine Learning analysis of blood biomarkers with ApoE genotype and age assessment to enable early detection and personalized medicine approaches.
Fujirebio Diagnostics,Inc. · China
A cerebrospinal fluid detection test for Alzheimer's disease core biomarkers that provides enhanced sensitivity and more accurate results. This product targets the pathological hallmarks of Alzheimer's disease.
97 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products